Emery Pharma to Exhibit at Pharmaceutical Bioscience Society (PBSS) Events in Foster City, California
Emery Pharma is excited to announce its attendance and exhibition at the following Pharmaceutical Bioscience Society events in Foster City, CA. These events will gather industry leaders and innovators, providing a unique platform to share the latest advancements in pharmaceutical developments.
- Translational PK/PD and Human Dose Projection for Antibodies/ADCs and Novel Therapeutic Modalities (September 10, 2024)
- Nonclinical Safety Assessments of Biologics and Other Novel Modalities for IND/NDA/BLA Filings (September 20, 2024)
- Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA (October 10, 2024)
- Clinical Pharmacology Studies on Hepatic and Renal Impairments for NDA Filing: Strategies, Design, Conduct, Analysis and Regulatory Aspects (November 1, 2024)
- Current State of Bioanalysis for Biologics and Cell/Gene Therapy Products: Refining Established Approaches for New Complex Therapies (November 15, 2024)
At PBSS, Emery Pharma will be showcasing its extensive capabilities within the pharmaceutical development process with how it relates to ADCs, mAbs, small molecule and peptide therapeutics.
As a Contract Research Organization (CRO) with expertise in bioanalysis and therapeutic development, Emery Pharma is dedicated to expediting the journey to a cure through innovative science and comprehensive data analysis.
For media inquiries, please contact:
Chris Purcell
Business Development Manager
Emery Pharma
